Brackmann Christoph
SEC insider (Form 3/4/5 filer). CIK 0002048634. Chief Financial Officer at NovoCure Ltd (NVCR). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in WAYNE, PA.
Companies Brackmann Christoph has filed insider reports for
- NovoCure Ltd (NVCR): Officer, Chief Financial Officer
Brackmann Christoph
CIK: 0002048634
Transaction Breakdown
Open Market Buys (P)3 (42.9%)
High conviction signal
Open Market Sales (S)1 (14.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCR
NovoCure Ltd
Officer
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 4, 2026NVCR
NovoCure Ltd
SaleDirect6.4K shares at avg. $13.31$85K - Mar 3, 2026NVCR
NovoCure Ltd
AwardDirect55.1K shares- - Nov 4, 2025NVCR
NovoCure Ltd
Tax PaymentDirect7K shares at avg. $12.23$86K - Jul 29, 2025NVCR
NovoCure Ltd
PurchaseDirect5K shares at avg. $11.50$58K - Jul 29, 2025NVCR
NovoCure Ltd
PurchaseDirect10K shares at avg. $11.63$116K - Jul 29, 2025NVCR
NovoCure Ltd
PurchaseDirect5K shares at avg. $11.60$58K - Mar 4, 2025NVCR
NovoCure Ltd
AwardDirect55K shares at avg. $18.19$1000K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | NVCR NovoCure Ltd | Sale | 6,412 | $13.31 | $85,314 | Direct |
| Mar 3, 2026 | NVCR NovoCure Ltd | Award | 55,137 | - | $0 | Direct |
| Nov 4, 2025 | NVCR NovoCure Ltd | Tax Payment | 7,033 | $12.23 | $86,014 | Direct |
| Jul 29, 2025 | NVCR NovoCure Ltd | Purchase | 5,000 | $11.50 | $57,500 | Direct |
| Jul 29, 2025 | NVCR NovoCure Ltd | Purchase | 10,000 | $11.63 | $116,300 | Direct |
| Jul 29, 2025 | NVCR NovoCure Ltd | Purchase | 5,000 | $11.60 | $58,000 | Direct |
| Mar 4, 2025 | NVCR NovoCure Ltd | Award | 54,975 | $18.19 | $999,995 | Direct |
1-7 of 7 transactions